2002, Número S1
<< Anterior Siguiente >>
Gac Med Mex 2002; 138 (S1)
Nuevas Direcciones en enfermedad de célula de Hoz
Scott-Manno C
Idioma: Español
Referencias bibliográficas: 6
Paginas: 10-11
Archivo PDF: 22.35 Kb.
FRAGMENTO
No tiene resumen
REFERENCIAS (EN ESTE ARTÍCULO)
Adams RJ, McVie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Dopple r ultrasonography. New Engl J Med 1998;339:5.
Adams RJ, McVie VC, Carl EM et al. Long-term risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997;42:699.
Charache S et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995,332:1317.
Kinney T et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood 1999;94:1550.
Maier-Redelsperger M et al. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. Blood 1998;91:4472.
O’Brien KL, Swift AJ, Winkelstein JA et al. Safety and immunogenicity of heptavalent pneumoccal vaccine conjugated to CRM197 among infants with sickle cell disease. Pediatrics 2000;106,965.